Pulmonary Arterial Hypertension after Ibuprofen Treatment for Patent Ductus Arteriosus in Very Low Birth Weight Infants

Journal of Pediatrics

Volumn 179, Issue , 2016, Pages 49-53.e1

  Kim, Sae Yun ^a,b   Shin, Seung Han ^a   Kim, Han Suk ^a   Jung, Young Hwa ^a   Kim, Ee Kyung ^a   Choi, Jung Hwan ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

adverse effect; cyclooxygenase inhibitors; premature infant

Indexed keywords

IBUPROFEN; IBUPROFEN LYSINE; IBUPROFEN TROMETAMOL; UNCLASSIFIED DRUG; PROSTAGLANDIN SYNTHASE INHIBITOR;

AGE; ARTICLE; BIRTH WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL HYPERTENSION; MEDICAL RECORD REVIEW; NEONATAL INTENSIVE CARE UNIT; OLIGOHYDRAMNIOS; PATENT DUCTUS ARTERIOSUS; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK FACTOR; UNIVERSITY HOSPITAL; VERY LOW BIRTH WEIGHT; CHEMICALLY INDUCED; DUCTUS ARTERIOSUS, PATENT; NEWBORN;

COHORT STUDIES; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IBUPROFEN; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; RETROSPECTIVE STUDIES;

EID: 84997207598     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.08.103     Document Type: Article

References (24)

1. 1 Noori, S., McCoy, M., Friedlich, P., Bright, B., Gottipati, V., Seri, I., et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics, 123, 2009 e138-44.
2. 2 Clyman, R.I., Ibuprofen and patent ductus arteriosus. N Engl J Med 343 (2000), 728–730.
3. 3 Heuchan, A.M., Clyman, R.I., Managing the patent ductus arteriosus: current treatment options. Arch Dis Child Fetal Neonatal Ed, 99, 2014 F431-6.
4. 4 Ohlsson, A., Walia, R., Shah, S.S., Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev(4), 2015 CD003481.
5. 5 Gournay, V., Savagner, C., Thiriez, G., Kuster, A., Roze, J., Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 359 (2002), 1486–1488.
6. 6 Amendolia, B., Lynn, M., Bhat, V., Ritz, S.B., Aghai, Z.H., Severe pulmonary hypertension with therapeutic l-lysine ibuprofen in 2 preterm neonates. Pediatrics, 129, 2012 e1360-3.
7. 7 Van Overmeire, B., Allegaert, K., Casaer, A., Debauche, C., Decaluwe, W., Jespers, A., et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 364 (2004), 1945–1949.
8. 8 Fenton, T.R., Kim, J.H., A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr, 13, 2013, 59.
9. 9 Ballard, R.A., Truog, W.E., Cnaan, A., Martin, R.J., Ballard, P.L., Merrill, J.D., et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355 (2006), 343–353.
10. 10 Jobe, A.H., Bancalari, E., Bronchopulmonary dysplasia. Am J Respir Crit Care Med, 163, 2001.
11. 11 National High Blood Pressure Education Program, Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 183 (2000), s1–22.
12. 12 Aranda, J.V., Clyman, R., Cox, B., Van Overmeire, B., Wozniak, P., Sosenko, I., et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 26 (2009), 235–245.
13. 13 Adamska, E., Helwich, E., Rutkowska, M., Zacharska, E., Piotrowska, A., [Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants]. Med Wieku Rozwoj 9 (2004), 335–354.
14. 14 Yadav, S., Agarwal, S., Maria, A., Dudeja, A., Dubey, N.K., Anand, P., et al. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial. Pediatr Cardiol 35 (2014), 824–830.
15. 15 Gournay, V., Roze, J., Kuster, A., Daoud, P., Cambonie, G., Hascoet, J., et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 364 (2004), 1939–1944.
16. 16 Rackley, C.R., Stripp, B.R., Building and maintaining the epithelium of the lung. J Clin Invest, 122, 2012, 2724.
17. 17 Regev, R.H., Lusky, A., Dolfin, T., Litmanovitz, I., Arnon, S., Reichman, B., et al. Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study. J Pediatr 143 (2003), 186–191.
18. 18 Peacock, J.L., Lo, J.W., D'Costa, W., Calvert, S., Marlow, N., Greenough, A., Respiratory morbidity at follow-up of small-for-gestational-age infants born very prematurely. Pediatr Res 73 (2012), 457–463.
19. 19 Kim, D.-H., Kim, H.-S., Choi, C.W., Kim, E.-K., Kim, B.-I., Choi, J.-H., Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology 101 (2012), 40–46.
20. 20 Nicolini, U., Fisk, N.M., Rodeck, C.H., Talbert, D.G., Wigglesworth, J.S., Low amniotic pressure in oligohydramnios—is this the cause of pulmonary hypoplasia?. Am J Obstet Gynecol 161 (1989), 1098–1101.
21. 21 Jayet, P.-Y., Rimoldi, S.F., Stuber, T., Salmòn, C.S., Hutter, D., Rexhaj, E., et al. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation 122 (2010), 488–494.
22. 22 Lazdam, M., de la Horra, A., Pitcher, A., Mannie, Z., Diesch, J., Trevitt, C., et al. Elevated blood pressure in offspring born premature to hypertensive pregnancy: is endothelial dysfunction the underlying vascular mechanism?. Hypertension 56 (2010), 159–165.
23. 23 Silasi, M., Cohen, B., Karumanchi, S.A., Rana, S., Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 37 (2010), 239–253.
24. 24 Bueters, R.R., Klaasen, A., Maicas, N., Florquin, S., van den Heuvel, L.P., Schreuder, M.F., Impact of early postnatal NSAID treatment on nephrogenesis in Wistar rats. Birth Defects Res B Dev Reprod Toxicol 104 (2015), 218–226.